No approved sexual-health dose is established for men. Research-product use should not be extrapolated from the female prescription label.
Prescription ingredient
Sexual health & pigmentation
PT-141 / Bremelanotide
Bremelanotide is a melanocortin agonist with a prescription product authorized in some jurisdictions for a narrow female sexual-health indication.
PT-141 / Bremelanotide10 mg
Add a Featured Image in WordPress to replace this product placeholder.
ClassificationMelanocortin receptor agonist
Catalogue strength10 mg
Current contextPrescription ingredient
What it is
Bremelanotide is a melanocortin agonist with a prescription product authorized in some jurisdictions for a narrow female sexual-health indication.
Its catalogue classification is melanocortin receptor agonist. Status and formulation matter: a research-labelled vial is not automatically equivalent to an authorized prescription medicine containing a similarly named ingredient.
What it is studied or used for
- Melanocortin signalling
- Female hypoactive sexual desire disorder
- Neuroendocrine sexual-response pathways
A research topic is not proof of a health benefit. Evidence can range from cell and animal models to controlled human trials, and those levels should not be treated as equivalent.
How it is used or administered
Authorized route and schedule depend on the exact prescription product, indication and patient. Use only when prescribed and dispensed by qualified professionals.
Dosing context for men and women
An authorized product exists in some jurisdictions for selected premenopausal women, but the prescription formulation, screening, frequency limits and blood-pressure precautions are essential.
Why no universal number? Dose depends on the exact formulation, legal status, indication, concentration, patient factors and monitoring. Publishing a single male or female number would be misleading and unsafe.
Active shelf life and storage
Follow the printed expiry and the dispensing label. Shelf life cannot be transferred between brands, concentrations, compounded products or reconstituted preparations.
Follow the manufacturer and pharmacy label for the exact dispensed formulation. Temperature limits can differ between tablets, creams and injectable products.
What it may be paired with
Do not combine casually with other sexual-health medicines. Blood-pressure effects, nausea and delayed gastric emptying may complicate other medications.
Safety boundary
The presence of an approved active ingredient does not establish that every formulation or seller is authorized.
Continue with primary sources
Evidence and regulatory status change. Verify the exact active ingredient, formulation and jurisdiction before drawing conclusions.
Product availability
View PT-141 / Bremelanotide on the main site ↗
Ready to leave the education library?
Purchasing, pricing, shipping and product-specific lot information are handled on the main Cryos Bio Labs website.